Drug intelligence / Profile preview

type AB plasma

Development stage
Phase 2
Lead developer
American Red Cross
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Type AB plasma is a blood-derived therapeutic component obtained from donors with the AB blood group. It is characterized by the absence of both anti-A and anti-B isoagglutinins (antibodies) in the plasma, which allows it to be transfused into recipients of any ABO blood type without causing hemolytic transfusion reactions. Consequently, it is designated as the "universal donor" for plasma. Clinically, it is indicated for the management of massive hemorrhage, replacement of multiple coagulation factors (e.g., in liver disease or disseminated intravascular coagulation), and in ABO-incompatible organ transplantation protocols to manage antibody levels. Due to the rarity of the AB blood type (approximately 4% of the population), it is often in short supply and prioritized for emergency use when the recipient's blood type is unknown.

Other names
AB plasmauniversal plasmafresh frozen plasma, type ABhuman type AB plasma
02

Targets

F (Coagulation factors)

Beyond the preview

Go deeper on type AB plasma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on type AB plasma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call